Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Systemic Inflammation Induces Release of Cell-Free DNA from Hematopoietic and Parenchymal Cells in Mice and Human

Anna Kroeze, MD, Anne Jan van der Meer, MD, Arie J Hoogendijk, PhD, Aicha Ait Soussan, C. Ellen van der Schoot, MD PhD, Walter A Wuillemin, MD PhD, Carlijn Voermans, PhD, Tom van der Poll, MD PhD, Sacha S Zeerleder, MD PhD

Blood (2018) 132 (Supplement 1): 1107.

https://doi.org/10.1182/blood-2018-99-114468

Published: 2018

Journal Articles

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families

Willem M. Lijfering, Nic J. G. M. Veeger, Saskia Middeldorp, Karly Hamulyák, Martin H. Prins, Harry R. Büller, Jan van der Meer

Blood (2009) 114 (10): 2031–2036.

https://doi.org/10.1182/blood-2009-04-215418

Published: 2009

Journal Articles

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives

Willem M. Lijfering, Jan-Leendert P. Brouwer, Nic J. G. M. Veeger, Ivan Bank, Michiel Coppens, Saskia Middeldorp, Karly Hamulyák, Martin H. Prins, Harry R. Büller, Jan van der Meer

Blood (2009) 113 (21): 5314–5322.

https://doi.org/10.1182/blood-2008-10-184879

Published: 2009

Journal Articles

Clinical relevance of decreased free protein S levels: results from a retrospective family cohort study involving 1143 relatives

Willem M. Lijfering, Rene Mulder, Min Ki ten Kate, Nic J. G. M. Veeger, Andre B. Mulder, Jan van der Meer

Blood (2009) 113 (6): 1225–1230.

https://doi.org/10.1182/blood-2008-08-174128

Published: 2009

Journal Articles

Early Minor Bleeding as Risk Indicator for Major Bleeding in Patients Using Vitamin-K-Antagonists, Independent of Quality of Anticoagulation.

Nic J.G.M. Veeger, Margriet Piersma-Wichers, Hans L. Hillege, Jan van der Meer

Blood (2008) 112 (11): 987.

https://doi.org/10.1182/blood.V112.11.987.987

Published: 2008

Journal Articles

Hereditary Deficiencies of Protein C or Protein S Confer Increased Risk of Arterial Thromboembolic Events at Young Age. Results from a Large Family Cohort Study

Bakhtawar Khan Mahmoodi, Jan-Leendert P. Brouwer, Nic J.G.M. Veeger, Jan van der Meer

Blood (2008) 112 (11): 422.

https://doi.org/10.1182/blood.V112.11.422.422

Published: 2008

Journal Articles

Free Protein S Levels on the Risk of First Venous Thrombosis and Recurrence. Results from a Retrospective Family Cohort Study in 1143 Relatives.

Willem M Lijfering, MD, René Mulder, Min Ki ten Kate, Andre Mulder, Jan van der Meer

Blood (2008) 112 (11): 1808.

https://doi.org/10.1182/blood.V112.11.1808.1808

Published: 2008

Journal Articles

High Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels May Protect against Recurrent Fetal Loss.

Hendrika M Knol, Nic J.G.M. Veeger, Saskia Middeldorp, Karly Hamulyàk, Martin H Prins, Harry R Büller, Jan van der Meer

Blood (2008) 112 (11): 1815.

https://doi.org/10.1182/blood.V112.11.1815.1815

Published: 2008

Journal Articles

Microalbuminuria Is Associated with An Increased Risk of Venous Thromboembolism. A Novel Risk Marker for Venous Thromboembolism

Bakhtawar Khan Mahmoodi, Ron T. Gansevoor, Nic J.G.M. Veeger, Hans L. Hillege, Gerjan Navis, Jan van der Meer

Blood (2008) 112 (11): 523.

https://doi.org/10.1182/blood.V112.11.523.523

Published: 2008

Journal Articles

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Willem M. Lijfering, MD, Michiel Coppens, MD, Nic J.G.M. Veeger, MSc, Saskia Middeldorp, MD, PhD, Karly Hamulyak, MD, PhD, Martin H. Prins, MD, Phd, Harry R. Buller, MD, PhD, Jan van der Meer, Md, PhD

Blood (2007) 110 (11): 130.

https://doi.org/10.1182/blood.V110.11.130.130

Published: 2007

Journal Articles

Increased Prothrombotic State in Patients with Advancing HIV Disease.

Willem M. Lijfering, MD, Herman G. Sprenger, MD, Rita R. Georg, Piet A. van der Meulen, Jan van der Meer, MD, PhD

Blood (2007) 110 (11): 2274.

https://doi.org/10.1182/blood.V110.11.2274.2274

Published: 2007

Journal Articles

Natural Course of the Subsequent Pregnancy after a Single Loss in Women with and without the Factor V Leiden or Prothrombin 20210A Mutations.

Michiel Coppens, Nienke Folkeringa, Margreet Teune, Karly Hamulyak, Jan van der Meer, Martin H. Prins, Harry R. Büller, Saskia Middeldorp

Blood (2006) 108 (11): 275.

https://doi.org/10.1182/blood.V108.11.275.275

Published: 2006

Journal Articles

Risk of Venous Thromboembolism Is Not Increased by Elevated TAFI Levels.

Nienke Folkeringa, MD, Jan Leendert P. Brouwer, MD, Nic J.G.M Veeger, MSc, Jan van der Meer, MD PhD

Blood (2006) 108 (11): 1484.

https://doi.org/10.1182/blood.V108.11.1484.1484

Published: 2006

Journal Articles

Methionine-Loading and Random Homocysteine Tests Have No Added Value in Risk Assessment for Venous and Arterial Thrombosis.

Willem M. Lijfering, MD, Nic J.G.M. Veeger, MSc, Jan-Leendert P. Brouwer, MD, Marlene H.W. van de Poel, MD, Jan van der Meer, MD PhD

Blood (2006) 108 (11): 1486.

https://doi.org/10.1182/blood.V108.11.1486.1486

Published: 2006

Journal Articles

High Risk of Pregnancy Related Venous Thromboembolism in Women with a Hereditary Deficiency of Antithrombin, Protein C or Protein S in Concomitance of Other Thrombophilic Defects: A Retrospective Cohort Study.

Nienke Folkeringa, MD, Jan-Leendert P. Brouwer, MD, Fleurisca J. Korteweg, MD, Nic J.G.M Veeger, MSc, Jan Jaap H.M. Erwich, MD PhD, Jan van der Meer, MD PhD

Blood (2006) 108 (11): 1485.

https://doi.org/10.1182/blood.V108.11.1485.1485

Published: 2006

Journal Articles

The Risk of Venous and Arterial Thrombosis in Hyperhomocysteinemic Subjects Is Caused by Elevated Factor VIII:C Levels.

Willem M. Lijfering, MD, Nic J.G.M. Veeger, MSc, Jan-Leendert P. Brouwer, MD, Marlene H.W. van de Poel, MD, Jan van der Meer, MD PhD

Blood (2006) 108 (11): 273.

https://doi.org/10.1182/blood.V108.11.273.273

Published: 2006

Journal Articles

Tendency towards Minor Bleeding in Women Is Associated with a Reduced Risk for Major Bleeding, without Apparent Differences in Level of Anticoagulation during Treatment with Vitamin K Antagonist.

Nic J.G.M. Veeger, MSc, Margriet Piersma-Wichers, MD, Jan van der Meer, MD, PhD

Blood (2006) 108 (11): 889.

https://doi.org/10.1182/blood.V108.11.889.889

Published: 2006

Journal Articles

A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation

Michiel Coppens, Marlene H. van de Poel, Ivan Bank, Karly Hamulyak, Jan van der Meer, Nic J. Veeger, Martin H. Prins, Harry R. Buller, Saskia Middeldorp

Blood (2006) 108 (8): 2604–2607.

https://doi.org/10.1182/blood-2006-04-016527

Published: 2006

Journal Articles

Hereditary Protein S Type III Deficiency Is Not a Risk Factor for Venous and Arterial Thrombosis, in Contrast to Protein S Deficiency Type I. Results from a Family Cohort Study To Assess the Clinical Impact of a Laboratory Based Classification.

Jan-Leendert P. Brouwer, MD, Nic J.G.M. Veeger, MSc, Wim van der Schaaf, Ing, Hanneke C. Kluin-Nelemans, MD PhD, Jan van der Meer, MD PhD

Blood (2004) 104 (11): 1056.

https://doi.org/10.1182/blood.V104.11.1056.1056

Published: 2004

Journal Articles

The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus

Jan-Leendert P. Brouwer, Marc Bijl, Nic J. G. M. Veeger, Hanneke C. Kluin-Nelemans, Jan van der Meer

Blood (2004) 104 (1): 143–148.

https://doi.org/10.1182/blood-2003-11-4085

Published: 2004

NARROW

Systemic Inflammation Induces Release of Cell-Free DNA from Hematopoietic and Parenchymal Cells in Mice and Human

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives

Clinical relevance of decreased free protein S levels: results from a retrospective family cohort study involving 1143 relatives

Early Minor Bleeding as Risk Indicator for Major Bleeding in Patients Using Vitamin-K-Antagonists, Independent of Quality of Anticoagulation.

Hereditary Deficiencies of Protein C or Protein S Confer Increased Risk of Arterial Thromboembolic Events at Young Age. Results from a Large Family Cohort Study

Free Protein S Levels on the Risk of First Venous Thrombosis and Recurrence. Results from a Retrospective Family Cohort Study in 1143 Relatives.

High Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels May Protect against Recurrent Fetal Loss.

Microalbuminuria Is Associated with An Increased Risk of Venous Thromboembolism. A Novel Risk Marker for Venous Thromboembolism

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Increased Prothrombotic State in Patients with Advancing HIV Disease.

Natural Course of the Subsequent Pregnancy after a Single Loss in Women with and without the Factor V Leiden or Prothrombin 20210A Mutations.

Risk of Venous Thromboembolism Is Not Increased by Elevated TAFI Levels.

Methionine-Loading and Random Homocysteine Tests Have No Added Value in Risk Assessment for Venous and Arterial Thrombosis.

High Risk of Pregnancy Related Venous Thromboembolism in Women with a Hereditary Deficiency of Antithrombin, Protein C or Protein S in Concomitance of Other Thrombophilic Defects: A Retrospective Cohort Study.

The Risk of Venous and Arterial Thrombosis in Hyperhomocysteinemic Subjects Is Caused by Elevated Factor VIII:C Levels.

Tendency towards Minor Bleeding in Women Is Associated with a Reduced Risk for Major Bleeding, without Apparent Differences in Level of Anticoagulation during Treatment with Vitamin K Antagonist.

A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation

Hereditary Protein S Type III Deficiency Is Not a Risk Factor for Venous and Arterial Thrombosis, in Contrast to Protein S Deficiency Type I. Results from a Family Cohort Study To Assess the Clinical Impact of a Laboratory Based Classification.

The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only